Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis

Background Knowledge about the genetic lesions that occur in Burkitt’s lymphoma, besides the pathognomonic IG-MYC translocations, is limited. Design and Methods Thirty-nine molecularly-defined Burkitt’s lymphomas were analyzed with high-resolution single-nucleotide polymorphism chips for genomic imbalances and uniparental disomy. Imbalances were correlated to expression profiles and selected micro-RNA analysis. Translocations affecting the MYC locus were studied by fluoresence in situ hybridization. Results We detected 528 copy number changes, defining 29 recurrently imbalanced regions. Five hundred and eighteen regions of uniparental disomy were found, but these were rarely recurrent. Combined imbalance mapping and expression profiling revealed a strong correlation between copy number and expression. Several recurrent imbalances affected the MYC pathway: the micro-RNA-supercluster 17-92 was frequently gained and the transcription factor E2F2 was recurrently deleted. Molecular Burkitt’s lymphoma lacking MYC translocations showed MYC gains. Amplifications of the polymerase iota gene were associated with increased frequency of positions scored as aberrant. Conclusions The present findings suggest that uniparental disomies do not play a major role in the pathogenesis of Burkitt’s lymphoma, whereas some genes may contribute to the development of this lymphoma through gene dosage effects. Amplifications of the polymerase iota gene may be functionally linked with increased genomic alterations in Burkitt’s lymphoma. The pattern and rarity of chromosomal changes detectable, even at the high resolution employed here, together with aberrations of genes regulating MYC activity, support the hypothesis that deregulation of the MYC pathway is the major force driving the pathogenesis of Burkitt’s lymphoma, but show that this deregulation is more complex than previously known.

[1]  W. Sanger,et al.  An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG‐5961 , 2010, British journal of haematology.

[2]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[3]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[4]  P. Dessen,et al.  High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma , 2009, PloS one.

[5]  J. Nevins,et al.  A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis , 2009, PLoS genetics.

[6]  Y. Asmann,et al.  A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.

[7]  M. Hermiston,et al.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells , 2009, Immunological reviews.

[8]  G. Mills,et al.  Uniparental disomy in cancer. , 2009, Trends in molecular medicine.

[9]  W. Klapper,et al.  GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma , 2009, British journal of haematology.

[10]  R. Siebert,et al.  Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.

[11]  S. Nakajima,et al.  Human DNA polymerase iota protects cells against oxidative stress , 2008, The EMBO journal.

[12]  G. Parmigiani,et al.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.

[13]  L. Staudt,et al.  Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma , 2008, Haematologica.

[14]  M. Ziepert,et al.  MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas , 2008, British journal of haematology.

[15]  R. Spang,et al.  Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. , 2008, Blood.

[16]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[17]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[18]  H. Tagawa,et al.  Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer development , 2007, Cancer science.

[19]  Vincent De Guire,et al.  An E2F/miR-20a Autoregulatory Feedback Loop* , 2007, Journal of Biological Chemistry.

[20]  M Loeffler,et al.  Development and Implementation of an Analysis Tool for Array-based Comparative Genomic Hybridization , 2007, Methods of Information in Medicine.

[21]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[22]  R. Siebert,et al.  Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma , 2006, Leukemia.

[23]  Wing Hung Wong,et al.  Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays , 2006, PLoS Comput. Biol..

[24]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  BRLMM : an Improved Genotype Calling Method for the GeneChip ® Human Mapping 500 K Array Set , 2006 .

[26]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[27]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[28]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[29]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[30]  Zhimin Chen,et al.  Altered DNA Polymerase ι Expression in Breast Cancer Cells Leads to a Reduction in DNA Replication Fidelity and a Higher Rate of Mutagenesis , 2004, Cancer Research.

[31]  R. Siebert,et al.  Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B‐cell lymphoma with MYC rearrangement , 2004, The Journal of pathology.

[32]  Cheng Li,et al.  dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..

[33]  Hiroyuki Tagawa,et al.  Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.

[34]  Luc Girard,et al.  An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. , 2004, Cancer research.

[35]  J. Martinez-Climent,et al.  Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study , 2003, Leukemia.

[36]  A. Sánchez-Aguilera,et al.  Cell cycle deregulation in B-cell lymphomas. , 2003, Blood.

[37]  J. Weill,et al.  Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota , 2002, Nature.

[38]  J. Aster,et al.  Molecular biology of Burkitt's lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  K. Magnússon,et al.  p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. , 1998, Blood.

[40]  G. Gaidano,et al.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.